Pharmaceutical
| Fri 09 Jan 2026
Alexandria, Jan. 10 -- BioVersys has secured a patent on 3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one Derivatives. Bourotte Marilyne, Pieren Michel, Lociuro Sergio, Gitzinger Marc, Kemmer Christian, Schellhorn Birgit, Schill Julian and Schneider Peter developed the invention.
The patent application number is U..